《瑞銀窩輪》捕捉大市走勢 兩手準備恆指認購(22730)、恆指認沽(15702)
港股周一曾失守18500點後,周二股市在濠賭股領升情況下,恆指亦受帶動,全日上升215點,收報18781點。
輪場方面,本周個股資金流整體偏淡靜,但由於港股周一時曾跌穿18500點,接近本年度低位18235點(三月中旬時低位),投資者以此為指標並積極部署買入恆指相關牛熊證以及認股證產品捕捉大市走勢。如投資者看好恆指後市表現,可留意恆指認購(22730),行使價20800點,23年2月到期,有效槓桿約10倍。如投資者看淡恆指,可留意恆指認沽(15702),行使價17000點,22年12月到期,有效槓桿約9.8倍。當然投資者亦可以恆指牛熊證作即市操作,由於近日市況較為波動,在選擇恆指牛熊證產品時應時刻注意相關收回價,甚至選擇收回價較遠的產品以避免收回風險。
另外,市場亦靜待美國周四公佈的最新聯儲局FOMC會議結果,由於美國8月份CPI數據仍然高企,市場預測加息幅度至少達0.75厘,更有投行預料未來美國加息幅度或會更多以抗通脹問題。如投資者希望兩手準備捕捉美股走勢,看好可留意納指認購(10527),行使價14400點,23年3月到期,有效槓桿約9.4倍,或道指認購(10620),行使價35000點,23年3月到期,有效槓桿約10倍。如看淡美股,可留意納指認沽(10528),行使價10750點,22年12月到期,有效槓桿約7.8倍,或道指認沽(10497),行使價24400點,22年12月到期,有效槓桿約11倍。
近日本港疫情漸趨穩定,確診數字亦有所回落,有傳港府或考慮放寬來港檢疫安排,希望採取「0+7」,即以七天的居家醫學監察全面取代酒店檢疫安排,有傳港府正研究確實的執行方式,當落實相關安排後便會再作公佈。周二濠賭股如金沙(01928)、銀娛(00027)股價即受帶動,金沙股價漲升7.7%,收報19.3港元,而銀娛方面股價亦上升4.3%,收報45.1港元。如投資者憧憬放寬來港檢疫安排有助港、澳通關並帶動濠賭業發展,看好金沙的投資者可留意金沙認購(22629),行使價24.43港元,23年3月到期,有效槓桿約4.9倍。如投資者看好銀河,可留意銀河認購(24302),行使價55.05港元,23年1月到期,有效槓桿約8.5倍。另外,航空股如國泰(00293)近日表現亦因此而呈一大上升軌道,自上周開始亦已升穿其50天線水平,至於周二表現,國泰股價續升2.2%,收報8.8港元。如投資者憧憬放寬政策可以帶動航空股的股價,看好國泰可留意國泰認購(23193),行使價9.89港元,23年4月到期,有效槓桿約6.1倍。
更多窩輪牛熊資訊:瑞銀認股證牛熊證網站: http://www.ubs.com/hkwarrants
輪證教學及巿況焦點短片:
https://www.youtube.com/channel/UCKw86qy4eBAInmd52MND45Q?view_as=subscriber
謝宛彤
副董事
瑞銀亞洲股票衍生產品銷售部
本產品並無抵押品。 如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。筆者為UBS AG的代表(作為證監會持牌人),並未持有相關上市公司的任何財務權益。本資料由瑞銀刊發,其並不構成買賣建議、邀請、要約或遊說。結構性產品價格可急升或急跌,投資者可能會蒙受全盤損失。過往表現並不反映將來表現。牛熊證備強制贖回機制而可能被提早終止,屆時 (i) N類牛熊證投資者將不獲發任何金額;而(ii) R類牛熊證之剩餘價值可能為零。投資前應瞭解有關風險,並諮詢專業顧問及查閱有關上市檔。UBS Securities Hong Kong Limited為結構性產品之流通量提供者,亦可能是唯一報價者或巿場參與者。(C) UBS 2022。版權所有。~
重要聲明:
以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.